Antonella Bruzzese

19PUBLICATIONS
25CO-AUTHORS
Haematological tumoursMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Oct 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating Agents.

Ernesto Vigna, Antonella Bruzzese, Enrica Antonia Martino

|Oct 08, 2025
Herpes Zoster in Hematological Disorders: Pathogenesis, Risk Stratification, and Emerging Strategies for Prevention and Immunization.

Enrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese

|Jun 23, 2025
Treatment-Free Remission in Chronic Myeloid Leukemia: Revisiting the "W" Questions.

Antonella Bruzzese, Ernesto Vigna, Enrica Antonia Martino

|Apr 13, 2025
Rilzabrutinib for the Treatment of Immune Thrombocytopenia.

Caterina Labanca, Enrica Antonia Martino, Ernesto Vigna

|Mar 19, 2025
Prognostic Significance of +1q Alterations in Relapsed/Refractory Multiple Myeloma Treated With Daratumumab-, Elotuzumab-, and Carfilzomib-Based Triplet Regimens: A Multicenter Real-World Analysis of 635 Patients.

Fortunato Morabito, Enrica Antonia Martino, Monica Galli

|Mar 06, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies.

Antonella Bruzzese, Enrica Antonia Martino, Caterina Labanca

Pageof 4

Frequent Collaborators

12 joint publications

Fortunato Morabito

8 joint publications

Massimo Gentile

3 joint publications

Francesco Mendicino

3 joint publications

Emiliano Barbieri